Below are the earnings highlights for Outlook Therapeutics, Inc. (OTLK):
Earnings: $17.3 million in Q1 vs. -$11.1 million in the same period last year. EPS: $0.72 in Q1 vs. -$0.86 in the same period last year. Excluding items, Outlook Therapeutics, Inc. reported adjusted earnings of -$21.5 million or -$0.89 per share for the period.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.